Auditory Hallucination, Verbal, Treatment-resistant Schizophrenia
Conditions
Keywords
auditory hallucination, schizophrenia, treatment-resistant, psychotherapy, virtual reality, avatar
Brief summary
Treatment of verbal hallucinations in schizophrenia is clinically challenging for both the patient and the therapist. For the therapist, one of the main difficulties arises from the impossibility of directly communicating with the entity persecuting the patient. For the patient, the therapeutic process is challenging because it aims at getting to better cope with an entity that keeps repeating stereotyped and abusive sentences without having the emotional strength to reply to the persecutor. To help overcome these clinical challenges, virtual reality enable patients to recreate the face and the voice of their persecutor.The hypothesis is that the engagement of patients in a dialogue with an external representation of their persecutor, with the support of the therapist, would help them to gain better control over their voices.
Interventions
BEHAVIORALAvatar therapy
Patients will receive 6 sessions of avatar therapy consisting of 45 minute (1 session per week). The therapy will consist in prompting patients to enter in a dialogue with their persecutor to better regulate their emotional responses. Over the course of the therapy, the character of the avatar will progressively become under patients' control. More precisely, the avatar's speech and tone will gradually be changed by the therapist to echo patients' improved ability to regulate their emotions. That is, the avatar will progressively change from being abusive to becoming helpful and supportive. By doing so, the therapy will seek to reinforce patients' feeling of empowerment over their voices.
OTHERTreatment-as-usual
Treatment as usual will consist of typical or atypical antipsychotic medication and regulars appointments with psychiatrists and others care team members for a period of 6 weeks.
Sponsors
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
Ciusss de L'Est de l'Île de Montréal
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Partial crossover design
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* distressing auditory verbal hallucinations * medication resistance relating to auditory verbal hallucinations (no response after 3 antipsychotics trials lasting at least 4 weeks each with a minimum of 400mg chlorpromazine equivalent) * DSM-5 diagnosis of schizophrenia or schizoaffective disorder
Exclusion criteria
* any change in medication within the past 2 months; * substance use disorder within the last 12 months * neurological disorder or unstable and serious physical illness * ongoing psychotic episode * cognitive behavioural therapy for psychosis within the last 12 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Psychotic Symptom Rating Scale - auditory hallucinations | Within 1 week before treatment, within 1 week after treatment, follow-up 3 months | 11-item structured interview assessing the severity of auditory hallucinations |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Beliefs About Voices Questionnaire - Revised | Within 1 week before treatment, within 1 week after treatment, follow-up 3 months | 35-item self-report measure designed to assess key beliefs and responses people have concerning their voice |
| Change in Positive And Negative Syndrome Scale | Within 1 week before treatment, within 1 week after treatment, follow-up 3 months | 30-item semi-structured interview investigating overall symptoms severity of schizophrenia in the last week |
| Change in Beck Depression Inventory - II | Within 1 week before treatment, within 1 week after treatment, follow-up 3 months | 21-item self-report measure assessing depression symptoms over the past 2 weeks |
| Change in Quality of Life Enjoyment and Satisfaction Questionnaire - Short From | Within 1 week before treatment, within 1 week after treatment, follow-up 3 months | 16-item self-report scale measuring enjoyment and satisfaction experienced during the past week in various areas of daily functioning |
Other
| Measure | Time frame | Description |
|---|---|---|
| Change in Self-reported anxiety, fear and presence | Last 10 min of each therapy session | 3-item self-report scale, ranging from 0 (no emotion) to 10 (strongest emotion) |
Countries
Canada
Outcome results
None listed